Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)

由 Schwarz, Lilian, Vernerey, Dewi, Bachet, Jean-Baptiste, Tuech, Jean-Jacques, Portales, Fabienne, Michel, Pierre, Cunha, Antonio Sa
發表在 BMC Cancer (2018)

Correction to: Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 s...

由 Schwarz, Lilian, Vernerey, Dewi, Bachet, Jean-Baptiste, Tuech, Jean-Jacques, Portales, Fabienne, Michel, Pierre, Cunha, Antonio Sa
發表在 BMC Cancer (2020)

Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study

由 Sgarbura, Olivia, Samalin, Emmanuelle, Carrere, Sébastien, Mazard, Thibault, de Forges, Hélène, Alline, Mathias, Pissas, Marie-Hélène, Portales, Fabienne, Ychou, Marc, Quenet, François
發表在 Pleura Peritoneum (2016)

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

由 Portales Fabienne, Bachet Jean-Baptiste, Lepère Céline, Boyer-Gestin Christine, Assenat Eric, Mitry Emmanuel, Samalin Emmanuelle, Lièvre Astrid, Vaillant Jean-Nicolas, Ychou Marc, Rougier Philippe
出版 2009-09-01

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

由 Lièvre, Astrid, Samalin, Emmanuelle, Mitry, Emmanuel, Assenat, Eric, Boyer-Gestin, Christine, Lepère, Céline, Bachet, Jean-Baptiste, Portales, Fabienne, Vaillant, Jean-Nicolas, Ychou, Marc, Rougier, Philippe
出版 2009

Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial

由 Assenat, Eric, Desseigne, Francoise, Thezenas, Simon, Viret, Frédéric, Mineur, Laurent, Kramar, Andrew, Samalin, Emmanuelle, Portales, Fabienne, Bibeau, Frédéric, Crapez-Lopez, Evelyne, Bleuse, Jean Pierre, Ychou, Marc
出版 2011

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

由 Bachet, Jean-Baptiste, Wyrwicz, Lucjan, Price, Timothy, Cremolini, Chiara, Phelip, Jean-Marc, Portales, Fabienne, Ozet, Ahmet, Cicin, Irfan, Atlan, Dan, Becquart, Martin, Vidot, Loick, Mounedji, Nadjat, Van Cutsem, Eric, Taieb, Julien, Falcone, Alfredo
發表在 ESMO Open (2020)

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial...

由 Assenat, Eric, Azria, David, Mollevi, Caroline, Guimbaud, Rosine, Tubiana-Mathieu, Nicole, Smith, Denis, Delord, Jean-Pierre, Samalin, Emmanuelle, Portales, Fabienne, Larbouret, Christel, Robert, Bruno, Bibeau, Frédéric, Bleuse, Jean-Pierre, Crapez, Evelyne, Ychou, Marc, Pèlegrin, André
發表在 Oncotarget (2015)

The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

由 Van Cutsem, Eric, Mayer, Robert J., Laurent, Stéphanie, Winkler, Robert, Grávalos, Cristina, Benavides, Manuel, Longo-Munoz, Federico, Portales, Fabienne, Ciardiello, Fortunato, Siena, Salvatore, Yamaguchi, Kensei, Muro, Kei, Denda, Tadamichi, Tsuji, Yasushi, Makris, Lukas, Loehrer, Patrick, Lenz, Heinz-Josef, Ohtsu, Atsushi
發表在 Eur J Cancer (2017)

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

由 Van Cutsem, Eric, Tempero, Margaret A., Sigal, Darren, Oh, Do-Youn, Fazio, Nicola, Macarulla, Teresa, Hitre, Erika, Hammel, Pascal, Hendifar, Andrew E., Bates, Susan E., Li, Chung-Pin, Hingorani, Sunil R., de la Fouchardiere, Christelle, Kasi, Anup, Heinemann, Volker, Maraveyas, Anthony, Bahary, Nathan, Layos, Laura, Sahai, Vaibhav, Zheng, Lei, Lacy, Jill, Park, Joon Oh, Portales, Fabienne, Oberstein, Paul, Wu, Wilson, Chondros, Dimitrios, Bullock, Andrea J.
發表在 J Clin Oncol (2020)